netFormulary
 Report : A-Z CDF items in Formulary 30/03/2020 19:55:27
[Back]
 
Section Status CDF Name
08.03.04.02 Formulary Cancer Drugs Fund Abiraterone Zytiga
08.01.05 Non Formulary Cancer Drugs Fund Aflibercept Zaltrap
08.02.03 Formulary Cancer Drugs Fund Atezolizumab Tecentriq
08.01.01 Formulary Cancer Drugs Fund Bendamustine Levact
08.01.05 Restricted Use Cancer Drugs Fund Bevacizumab Avastin
08.01.05 Restricted Use Cancer Drugs Fund Bevacizumab Avastin
08.01.05 Formulary Cancer Drugs Fund Bortezomib Velcade
08.01.05 Formulary Cancer Drugs Fund Bosutinib Bosulif
08.01.05 Formulary Cancer Drugs Fund Brentuximab vedotin Adcetris
08.01.05 Formulary Cancer Drugs Fund Cabazitaxel Jevtana
08.01.05 Formulary Cancer Drugs Fund Cabozantinib Cometriq
08.01.05 Formulary Cancer Drugs Fund Ceritinib Zykadia
08.01.05 Formulary Cancer Drugs Fund Cetuximab Erbitux
08.01.05 Non Formulary Cancer Drugs Fund Cisplatin 
08.01.03 Formulary Cancer Drugs Fund Clofarabine Evoltra
08.01.05 Formulary Cancer Drugs Fund Crizotinib Xalkori
08.01.05 Formulary Cancer Drugs Fund Dabrafenib Tafinlar
08.01.05 Formulary Cancer Drugs Fund Dasatinib Sprycel
08.01.02 Formulary Cancer Drugs Fund Doxorubicin Caelyx
08.01 Formulary Cancer Drugs Fund Durvalumab Imfinzi®
08.03.04.02 Formulary Cancer Drugs Fund Enzalutamide Xtandi
08.01.05 Formulary Cancer Drugs Fund Eribulin Halaven
08.01.05 Formulary Cancer Drugs Fund Everolimus 
08.01.05 Formulary Cancer Drugs Fund Ibrutinib Imbruvica
08.01.05 Formulary Cancer Drugs Fund Imatinib Gilvec
08.01.05 Formulary Cancer Drugs Fund Ipilimumab Yervoy
08.02.04 Formulary Cancer Drugs Fund Lenalidomide Revlimid
08.01.03 Formulary Cancer Drugs Fund Nelarabine Atriance
08.02.04 Formulary Cancer Drugs Fund Nivolumab Opdivo
08.01.05 Formulary Cancer Drugs Fund Olaratumab Lartruvo
08.01.05 Formulary Cancer Drugs Fund Panitumumab Vectibix
08.01.03 Formulary Cancer Drugs Fund Pemetrexed Alimta
08.01.05 Formulary Cancer Drugs Fund Pertuzumab Perjeta
08.02.04 Formulary Cancer Drugs Fund Pomalidomide Imnovid
08.01.05 Formulary Cancer Drugs Fund Ponatinib Iclusig
08.03.04.02 Formulary Cancer Drugs Fund Radium-223 dichloride 
08.01.05 Formulary Cancer Drugs Fund Regorafenib Stivarga
08.01.05 Formulary Cancer Drugs Fund Sorafenib Nexavar
08.01.05 Formulary Cancer Drugs Fund Sunitinib Sutent
08.01.05 Non Formulary Cancer Drugs Fund Temsirolimus Torisel
08.01.05 Formulary Cancer Drugs Fund Trametinib Mekinist
08.01.05 Formulary Cancer Drugs Fund Trastuzumab Herceptin
08.01.05 Non Formulary Cancer Drugs Fund Vandetanib Caprelsa
08.01.05 Formulary Cancer Drugs Fund Venetoclax Venclyxto
Oxfordshire Clinical Commissioning Group